Epitope recognition of antibodies that define the sialomucin, endolyn (CD164), a negative regulator of haematopoiesis

Tissue Antigens

Volumn 65, Issue 3, 2005, Pages 220-239

  Jorgensen Tye, B ^a   Levesque, J P ^b   Royle, L ^c   Doyonnas, R ^a,d   Chan, J Y H ^a   Dwek, R A ^c   Rudd, P M ^c   Harvey, D J ^c   Simmons, P J ^b   Watt, Suzanne M ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d STANFORD UNIVERSITY   (United States)

Author keywords

CD164; Endolyn; Epitopes; Glycosylation; Inhibitory receptor; Sialomucins

Indexed keywords

AGGLUTININ; CD164 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CELL ADHESION MOLECULE; ENDOLYN; GLYCAN DERIVATIVE; MANNOSE; PEANUT AGGLUTININ; RECOMBINANT PROTEIN; SELECTIN; SIALOMUCIN; SIALYL LEWIS X ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; CELL PROLIFERATION; CONFORMATION; CONTROLLED STUDY; DATURA STRAMONIUM; EPITOPE MAPPING; GALANTHUS; GALANTHUS NIVALIS; HEMATOPOIESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIGAND BINDING; MASS SPECTROMETRY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; SAMBUCUS NIGRA; SIALYLATION;

AGGLUTININS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, CD; ANTIGENS, CD146; ANTIGENS, CD164; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPITOPE MAPPING; EXONS; GLYCOSYLATION; HEMATOPOIESIS; HUMANS; IMMUNODOMINANT EPITOPES; LECTINS; MICE; MUCINS; NEURAL CELL ADHESION MOLECULES; RECOMBINANT PROTEINS; SIALOMUCINS; TRANSCRIPTION FACTORS;

ARACHIS HYPOGAEA; DATURA STRAMONIUM; GALANTHUS NIVALIS; MAACKIA AMURENSIS; SAMBUCUS NIGRA;

EID: 20044384179     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2005.00358.x     Document Type: Article

References (57)

1. Watt SM, Buhring HJ, Rappold I et al. CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21. Blood 1998: 92: 849-66.
2. Zannettino AC, Buhring HJ, Niutta S, Watt SM, Benton MA, Simmons PJ. The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis. Blood 1998: 92: 2613-28.
3. Chan JY, Lee-Prudhoe JE, Jorgensen B et al. Relationship between novel isoforms, functionally important domains, and subcellular distribution of CD164/endolyn. J Biol Chem 2001: 276: 2139-52.
4. Doyonnas R, Yi-Hsin Chan J, Butler LH et al. CD164 monoclonal antibodies that block hemopoietic progenitor cell adhesion and proliferation interact with the first mucin domain of the CD164 receptor. J Immunol 2000: 165: 840-51.
5. Watt SM, Butler LH, Tavian M et al. Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues. Blood 2000: 95: 3113-24.
6. Watt SM, Chan JY. CD164 - a novel sialomucin on CD34+ cells. Leak Lymphoma 2000: 37: 1-25.
7. Doyonnas R, Kershaw DB, Duhme C et al. Anuria, omphalocele, and perinatal lethality in mice lacking the cd34-related protein podocalyxin. J Exp Med 2001: 194: 13-28.
8. Sassetti C, Tangemann K, Singer MS, Kershaw DB, Rosen SD. Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: parallels to Cd34. J Exp Med 1998: 187: 1965-75.
9. Takeda T, Go WY, Orlando RA, Farquhar MG. Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells. Mol Biol Cell 2000: 11: 3219-32.
10. Puri KD, Finger EB, Gaudernack G, Springer TA. Sialomucin CD34 is the major L-selectin ligand in human tonsil high endothelial venules. J Cell Biol 1995: 131: 261-70.
11. Fieger CB, Sassetti CM, Rosen SD. Endoglycan, a member of the CD34 family, functions as a L-selectin ligand through modification with tyrosine sulfation and sialyl Lewis X. J Biol Chem 2003: 278: 27390-8.
12. Cheng J, Baumhueter S, Cacalano G et al. Hematopoietic defects in mice lacking the sialomucin CD34. Blood 1996: 87: 479-90.
13. Katayama Y, Hidalgo A, Furie BC, Vestweber D, Furie B, Frenette PS. PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and α4 integrin. Blood 2003: 102: 2060-7.
14. Sperandio M, Smith ML, Forlow SB et al. P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venulies. J Exp Med 2003: 197: 1355-63.
15. Hicks AE, Nolan SL, Ridger VC, Hellewell PG, Norman KE. Recombinant P-selectin glycoprotein ligand-1 directly inhibits leukocyte rolling by all 3 selectins in vivo: complete inhibition of rolling is not required for anti-inflammatory effect. Blood 2003: 101: 3249-56.
16. Zannettino AC, Berndt MC, Butcher C, Butcher EC, Vadas MA, Simmons PJ. Primitive human hematopoietic progenitors adhere to P-selectin (CD62P). Blood 1995: 85: 3466-77.
17. Coombe DR, Watt SM, Parish CR. Mac-1 (CD116/CD18) and CD45 mediate the adhesion of hematopoietic progenitor cells to stromal cell elements via recognition of stromal heparan sulfate. Blood 1994: 84: 739-52.
18. Levesque JP, Zannettino AC, Pudney M et al. PSGL-1-mediated adhesion of human hematopoietic progenitors to P-selectin results in suppression of hematopoiesis. Immunity 1999: 11: 369-78.
19. Winkler IG, Snapp KR, Simmons PJ, Levesque J-P. Adhesion to E-selectin promotes growth inhibition and apoptosis of human and murine hematopoietic progenitor cells independent of PSGL-1. Blood 2004: 103: 1685-92.
20. Papayannopoulou T. Bone marrow homing: the players, the playfield, and their evolving roles. Curr Opin Hematol 2003: 10: 214-9.
21. Seveau S, Keller H, Maxfield FR, Piller F, Halbwachs-Mecarelli L. Neutrophil polarity and locomotion are associated with surface redistribution of leukosialin (CD43), an antiadhesive membrane molecule. Blood 2000: 95: 2462-70.
22. Snapp KR, Heitzig CE, Kansas GS. Attachment of the PSGL-1 cytoplasmic domain to the actin cytoskeleton is essential for leukocyte rolling on P-selectin. Blood 2002: 99: 4494-502.
23. Anzai N, Gotoh A, Shibayama H, Broxmeyer HE. Modulation of integrin function in hematopoietic progenitor cells by CD43 engagement: possible involvement of protein tyrosine kinase and phospholipase C-gamma. Blood 1999: 93: 3317-26.
24. He YW, Bevan MJ. High level expression of CD43 inhibits T cell receptor/CD3-mediated apoptosis. J Exp Med 1999: 190: 1903-8.
25. Miura Y, Mizutani C, Nishihara T et al. Adhesion via CD43 induces Syk activation and cell proliferation in TF-1 cells. Biochem Biophys Res Commun 2001: 288: 80-6.
26. Bazil V, Brandt J, Chen S et al. A monoclonal antibody recognizing CD43 (leukosialin) initiates apoptosis of human hematopoietic progenitor cells but not stem cells. Blood 1996: 87: 1272-81.
27. Fackler MJ, Krause DS, Smith OM, Civin CI, May WS. Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells. Blood 1995: 85: 3040-7.
28. Lee YN, Kang JS, Krauss RS. Identification of a role for the sialomucin CD164 in myogenic differentiation by signal sequence trapping in yeast. Mol Cell Biol 2001: 21: 7696-706.
29. Zannettino ACW, Rayner JR, Ashman LK, Gonda TJ, Simmons PJ. A powerful new technique for isolating genes encoding cell surface antigens using retroviral expression cloning. J Immunol 1996: 156: 611-20.
30. Zannettino ACW, Rappold I, Bühring HJ et al CD164 (MGC-24v) workshop panel report. In: Kishimoto T et al., eds. Leucocyte typing VI. New York: Garland Publishing Inc., 1997: 456-7.
31. Levesque J-P, Takada Y, Puzon-McLaughlin W, Simmons PJ. A novel monoclonal antibody recognizing a cation-dependent epitope within the regulatory loop of human β1 integrin (Cd29). Hybrid Hybridomics 2002: 21: 253-60.
32. Connolly NP, Jones M, Watt SM. Human Siglec-5: tissue distribution, novel isoforms and domain specificities for sialic acid-dependent ligand interactions. Br J Haematol 2002: 119: 221-38.
33. Merry AH, Bruce J, Bigge C, Ioannides A. Automated simultaneous release of intact and unreduced N and O-linked glycans from glycoproteins. Biochem Soc Trans 1992: 20: 91S.
34. Bigge JC, Patel TP, Bruce JA, Goulding PN, Charles SM, Parekh RB. Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal Biochem 1995: 230: 229-38.
35. Guile GR, Rudd PM, Wing DR, Prime SB, Dwek RA. A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal Biochem 1996: 240: 210-26.
36. Royle L, Mattu TS, Hart E et al. An analytical and structural database provides a strategy for sequencing O-glycans from microgram quantities of glycoproteins. Anal Biochem 2002: 304: 70-90.
37. Royle L, Roos A, Harvey DJ et al. Secretory IgA N- and O-glycans provide a link between the innate and adaptive immuno systems. J Biol Chem 2003: 278: 20140-53.
38. Wormald MR, Rudd PM, Harvey DJ, Chang SC, Scragg IG, Dwek RA. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry 1997: 36: 1370-80.
39. Masuzawa Y, Miyauchi T, Hamanoue M et al. A novel core protein as well as polymorphic epithelial mucin carry peanut agglutinin binding sites in human gastric carcinoma cells: sequence analysis and examination of gene expression. J Biochem (Tokyo) 1992: 112: 609-15.
40. Sutherland DR, Abdullah KM, Cyopick P, Mellors A. Cleavage of the cell-surface O-sialoglycoproteins CD34, CD43, CD44, and CD45 by a novel glycoprotease from Pasteurella haemolytica. J Immunol 1992: 148: 1458-64.
41. Sutherland DR, Watt SM, Dowden G et al. Structural and partial amino acid sequence analysis of the human hemopoietic progenitor cell antigen CD34. Leukemia 1988: 2: 793-803.
42. Watt SM, Karhi K, Gatter K et al. Distribution and epitope analysis of the cell surface membrane glycoprotein (HPCA-1) associated with human hemopoietic progenitor cells. Leukemia 1987: 1: 417-26.
43. Galustian C, Childs RA, Stall M, Ishida H, Kiso M, Feizi T. Synergistic interactions of two classes of ligand, sialyl-Lewis (a/x) fuco-oligosaccharides and short sulpho-motifs, with the P- and L-selectins: implications for therapeutic inhibitor designs. Immunology 2002: 105: 350-9.
44. Leppanen A, Penttila L, Renkonen O, McEver RP, Cummings RD. Glycosulfopeptides with O-glycans containing sialylated and polyfucosylated polylactosamine bind with low affinity to P-selectin. J Biol Chem 2002: 277: 39749-59.
45. Leppanen A, Yago T, Otto VI, McEver RP, Cummings RD. Model glycosulfopeptides from P-selectin glycoprotein ligand-1 require tyrosine sulfation and a core 2-branched O-glycan to bind to L-selectin. J Biol Chem 2003: 278: 26391-400.
46. Andre P, Spertini O, Guia S et al. Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin. Proc Natl Acad Sci USA 2000: 97: 3400-5.
47. Li F, Wilkins PP, Crawley S, Weinstein J, Cummings RD, McEver RP. Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin. J Biol Chem 1996: 271: 3255-64.
48. Aeed PA, Geng JG, Asa D, Raycroft L, Ma L, Elhammer AP. Characterization of the O-linked oligosaccharide structures on P-selectin glycoprotein ligand-1 (PSGL-1). Glycoconj J 1998: 15: 975-85.
49. Wilkins PP, McEver RP, Cummings RD. Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells. J Biol Chem 1996: 271: 18732-42.
50. Moore KL, Eaton SF, Lyons DE, Lichenstein HS, Cummings RD, McEver RP. The P-selectin glycoprotein ligand from human neutrophils displays sialylated, fucosylated, O-linked poly-N-acetyllactosamine. J Biol Chem 1994: 269: 23318-27.
51. Satomaa T, Renkonen O, Helin J, Kirveskari J, Makitie A, Renkonen R. O-glycans on human high endothelial CD34 putatively participating in L-selectin recognition. Blood 2002: 99: 2609-11.
52. Hemmerich S, Leffler H, Rosen SD. Structure of the O-glycans in GlyCAM-1, an endothelial-derived ligand for L-selectin. J Biol Chem 1995: 270: 12035-47.
53. Mitsuoka C, Sawada-Kasugai M, Ando-Furui K et al. Identification of a major carbohydrate capping group of the 1-selectin ligand on high endothelial venules in human lymph nodes as 6-sulfo sialyl Lewis X. J Biol Chem 1998: 273: 11225-33.
54. Angata T, Brinkman-Van der Linden E. I-type lectins. Biochim Biophys Acta 2002: 1572: 294-316.
55. Crocker PR, Varki A. Siglecs in the immune system. Immunology 2001: 103: 137-45.
56. van den Berg TK, Nath D, Ziltener HJ et al. Cutting edge: CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin (Siglec-1). J Immunol 2001: 166: 3637-40.
57. Amano M, Galvan M, He J, Baum LG. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1 induced CD45 clustering, phosphatase modulation and T cell death. J Biol Chem 2003: 278: 7469-75.